Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR)

CUSIP: 29664W105

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
207,440,936
Total 13F shares
71,634,221
Share change
-5,484,032
Total reported value
$214,185,830
Put/Call ratio
31%
Price per share
$2.99
Number of holders
127
Value change
-$13,154,422
Number of buys
61
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2023

As of 31 Dec 2023, Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,634,221 shares. The largest 10 holders included WASATCH ADVISORS LP, Two Seas Capital LP, VANGUARD GROUP INC, Bellevue Group AG, Meditor Group Ltd, MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP. This page lists 127 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.